OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Moderna INC MODERNA ORD SHS/  US60770K1079  /

LSE International Off-book
2024-08-28  8:14:30 PM Chg. -0.18 Volume Bid2024-08-28 Ask2024-08-28 Market Capitalization Dividend Y. P/E Ratio
78.52USD -0.23% 10,161
Turnover: 805,452.79		 -Bid Size: - -Ask Size: - 30.12 bill.USD - -
TeleTrader 08-22 FDA okays Moderna, Pfizer updated vaccines
TeleTrader 08-01 Moderna's Q2 revenue down by 29.94% $241M
TeleTrader 05-02 Moderna surges 9% as Q1 revenue beat expectations
TeleTrader 05-02 Moderna sees $167M in Q1 revenue, beats forecasts
TeleTrader 04-24 Moderna, OpenAI partner on mRNA medicine advancement
TeleTrader 02-22 Moderna rallies 13% after earnings
TeleTrader 02-22 Moderna's Q4 revenue down 81% to $2.8 billion
TeleTrader 01-08 Moderna expects $4B in product sales in 2024
TeleTrader 2023-12-14 Moderna CEO: Melanoma vaccine could be available by 2025
TeleTrader 2023-11-02 Moderna: Q3 total revenue drops 46% to $1.8 billion
TeleTrader 2023-09-26 EU reportedly in talks with Moderna on COVID jab deal
TeleTrader 2023-09-12 CDC recommends updated Covid vaccines
TeleTrader 2023-09-11 FDA approves use of Moderna, Pfizer updated vaccines
TeleTrader 2023-08-03 Moderna's Q2 revenue plummets to $344M
TeleTrader 2023-07-05 Moderna to produce mRNA medicines in China
TeleTrader 2023-05-23 Moderna jumps 9% after clinical trial results
TeleTrader 2023-05-04 Moderna jumps 5% as Q1 revenue beats estimates
TeleTrader 2023-05-04 Moderna's Q1 revenue plunges 68% to $1.9B
TeleTrader 2023-04-20 Moderna, IBM reveal AI-backed mRNA research deal
TeleTrader 2023-04-11 Moderna sinks 5% as flu vaccine testing continues
TeleTrader 2023-03-10 Moderna announces US expansion and 2,000 new hires
TeleTrader 2023-03-06 Moderna to build new innovation, technology center in UK
TeleTrader 2023-02-23 Moderna: Q4 EPS drops 68% to $3.61
TeleTrader 2023-02-17 Moderna down 6.5% after flu shot study disappoints
TeleTrader 2023-01-18 Moderna rises 4% on optimism about RSV jab